Health Ministry turns to drug repurposing to combat dengue


Datuk Seri Dr Dzulkefly Ahmad (left) during the press conference on Monday. -Bernamapic

SHAH ALAM: The Health Ministry is using drug repurposing as part of its latest approach in the fight against the dengue disease, says Datuk Seri Dr Dzulkefly Ahmad.

The Health Minister said the development, which is at the clinical stage, is done together with the Dengue for Neglected Diseases initiative (DNDi) and the Institute of Medical Research (IMR).

“The research is aimed to repurpose existing antiviral drugs for dengue disease.

“There are four dengue stereotypes (DENV 1, DENV 2, DENV 3, and DENV 4), and in Malaysia, we have seen DENV1 and DENV2, but the most prominent is DENV2.

“The drug repurposing we are using currently has the same efficacy as the one used on those with Hepatitis C, which is called Nelfinavir. We are looking at several candidates presently,” he said.

He added that repurposing licensed drugs as a treatment against dengue was a smart and strategic method.

This is because producing a new drug costs a lot of money and is very time-consuming, he also said.

Dr Dzulkefly said this after officiating the Dengue Research Visibility Day 2024 at the National Health Institute here on Monday (March 4).

Also present were the Health director-general, Dr Muhammad Radzi Abu Hassan, and deputy director-general (research & technical support), Datuk Dr Nor Fariza Ngah.

The inaugural event calls for the shared commitment of nations and organisations in addressing the global challenges of dengue.

The collaborative efforts of the ministry with DNDi and other dengue-endemic countries were encapsulated in the Dengue Alliance, a global partnership established in 2022.

The alliance is dedicated to developing affordable and accessible treatments for dengue works on joint projects, advancing pre-clinical development of new drug candidates and clinical trials.

“The primary focus is conducting preclinical studies and trials with the aim of bringing cost-effective and accessible treatments to fruition within the next five years.

“Let’s hope for another success story played by the Dengue Alliance in developing a new elixir for the treatment of dengue patients akin to our previous successful joint efforts in Hepatitis,” he said.

The ministry recorded an 86.3% spike in the number of dengue cases in 2023 compared to the previous year.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Health Ministry , Dr Dzulkefly Ahmad , Dengue , IMR , DNDi

   

Next In Nation

Malaysia strongly condemns Israeli attack that injured humanitarian workers
Traffic congested on major highways heading towards Klang Valley
Anwar tenaciously steering country to greater heights, says his political secretary
Husband, wife killed after motorcycle crashes into tree in Jeli
MAS reroutes flights to avoid Iranian airspace amid Middle East tension
It's a prayer mat, not a door mat, say hypermarket chain and supplier
MCMC seizes phone, SIM card linked to spread of viral 'civil servant' clip
Sandakan cops on the hunt for man caught snatching handbag from car in viral video
Level 2 heatwave warning issued for Kedah's Pokok Sena, says MetMalaysia
Liew urges DBKK to slap maximum RM500 fine on litterbugs

Others Also Read